Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Other Non-Current Liabilities (2021 - 2023)

Climb Bio filings provide 2 years of Other Non-Current Liabilities readings, the most recent being $22000.0 for Q4 2023.

  • Quarterly Other Non-Current Liabilities changed N/A to $22000.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $22000.0 through Dec 2023, changed N/A year-over-year, with the annual reading at $22000.0 for FY2023, N/A changed from the prior year.
  • Other Non-Current Liabilities hit $22000.0 in Q4 2023 for Climb Bio, down from $34000.0 in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $87000.0 in Q1 2023 and bottomed at $7000.0 in Q4 2021.